Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cytoreduction followed by normothermic versus hyperthermic intraperitoneal intraoperative oxaliplatin chemoperfusion in peritoneal carcinomatosis
2012-000701-77Phase 2Completed
- Sponsor
- Ghent University Hospital
- Start
- Apr 2012
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of oxaliplatin in peritoneal carcinomatosis (PC), pseudomyxoma peritonei (PMP) and appendiceal mucinous neoplasm (MAN) (2 arms), sponsored by Ghent University Hospital. Primary endpoint: Pharmacokinetic analysis. Started Apr 2012; status: completed.
02
Drugs
oxaliplatin
03
Conditions
peritoneal carcinomatosis (PC)pseudomyxoma peritonei (PMP)appendiceal mucinous neoplasm (MAN)
Beyond the preview
Go deeper on 2012-000701-77.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000701-77.